| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.4M | -8.9% | +9.7% |
| SG&A Expense | $2.7M | -12.5% | -12.6% |
| Operating Income | -$5.0M | +10.9% | +3.4% |
| Interest Expense | $27K | -32.5% | -86.5% |
| Pre-tax Income | -$5.2M | +10.2% | -2.0% |
| Income Tax | $10K | +150.0% | +1100.0% |
| Net Income | -$5.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $11.0M | +82.3% | +396.5% |
| Total Assets | $14.0M | +50.0% | +110.7% |
| Current Liabilities | $5.2M | -3.0% | -55.2% |
| Long-term Debt | $600K | +0.0% | -74.7% |
| Total Liabilities | $6.8M | -6.1% | -58.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.2M | — | — |
| Investing Cash Flow | -$91K | — | — |
| Financing Cash Flow | $17.1M | — | — |
| +9.9% |
| -1.9% |
| EPS (Basic) | -$2.21 | -11.1% | -240.0% |
| EPS (Diluted) | -$2.21 | -11.1% | -240.0% |
| $6.9M |
| +292.2% |
| +170.6% |